<VariationArchive RecordType="classified" VariationID="2429130" VariationName="NC_000009.11:g.(104187910_104188836)_(104193180_104197990)del" VariationType="Deletion" Accession="VCV002429130" Version="4" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-11-11" DateCreated="2023-02-13" MostRecentSubmission="2023-11-11">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="2402563" VariationID="2429130">
      <GeneList>
        <Gene Symbol="ALDOB" FullName="aldolase, fructose-bisphosphate B" GeneID="229" HGNC_ID="HGNC:417" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>9q31.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="9" Accession="NC_000009.12" start="101420560" stop="101435774" display_start="101420560" display_stop="101435774" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="9" Accession="NC_000009.11" start="104182841" stop="104198061" display_start="104182841" display_stop="104198061" Strand="-" />
          </Location>
          <OMIM>612724</OMIM>
        </Gene>
      </GeneList>
      <Name>NC_000009.11:g.(104187910_104188836)_(104193180_104197990)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>9q31.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" forDisplay="true" AssemblyStatus="previous" Chr="9" Accession="NC_000009.11" outerStart="104187910" innerStart="104188836" innerStop="104193180" outerStop="104197990" display_start="104187910" display_stop="104197990" variantLength="10081" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000009.11" sequenceAccession="NC_000009" sequenceVersion="11" change="g.(104187910_104188836)_(104193180_104197990)del" Assembly="GRCh37">
            <Expression>NC_000009.11:g.(104187910_104188836)_(104193180_104197990)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000009.11:g.(104187910_104188836)_(104193180_104197990)del AND Hereditary fructosuria" Accession="RCV003123369" Version="3">
        <ClassifiedConditionList TraitSetID="131">
          <ClassifiedCondition DB="MedGen" ID="C0016751">Hereditary fructosuria</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-01-06" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-01-06" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2023-02-13" MostRecentSubmission="2023-11-11">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">20848650</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22494545</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">3430936</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="131" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="9641" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Hereditary fructosuria</ElementValue>
                <XRef ID="Hereditary+fructosuria/8519" DB="Genetic Alliance" />
                <XRef ID="20052008" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">FRUCTOSEMIA</ElementValue>
                <XRef Type="MIM" ID="229600" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Fructose intolerance</ElementValue>
                <XRef ID="HP:0005973" DB="Human Phenotype Ontology" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hereditary fructose intolerance</ElementValue>
                <XRef ID="MONDO:0009249" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Fructose-1-phosphate aldolase deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Aldolase B deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Fructose-1,6-bisphosphate aldolase B deficiency</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000505066" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000558338" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000505065" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000318892" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000319124" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6622" />
                <XRef ID="6622" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Following dietary exposure to fructose, sucrose, or sorbitol, untreated hereditary fructose intolerance (HFI) is characterized by metabolic disturbances (hypoglycemia, lactic acidemia, hypophosphatemia, hyperuricemia, hypermagnesemia, hyperalaninemia) and clinical findings (nausea, vomiting, and abdominal distress; chronic growth restriction / failure to thrive). While untreated HFI typically first manifested when fructose- and sucrose-containing foods were introduced in the course of weaning young infants from breast milk, it is now presenting earlier, due to the addition of fructose-containing nutrients in infant formulas. If the infant ingests large quantities of fructose, the infant may acutely develop lethargy, seizures, and/or progressive coma. Untreated HFI may result in renal and hepatic failure. If identified and treated before permanent organ injury occurs, individuals with HFI can experience a normal quality of life and life expectancy.</Attribute>
                <Citation Type="review" Abbrev="GeneReviews">
                  <ID Source="PubMed">26677512</ID>
                  <ID Source="BookShelf">NBK333439</ID>
                </Citation>
                <XRef ID="NBK333439" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">26677512</ID>
                <ID Source="BookShelf">NBK333439</ID>
              </Citation>
              <XRef ID="469" DB="Orphanet" />
              <XRef ID="C0016751" DB="MedGen" />
              <XRef ID="MONDO:0009249" DB="MONDO" />
              <XRef Type="MIM" ID="229600" DB="OMIM" />
              <XRef Type="primary" ID="HP:0005973" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="7081273" SubmissionDate="2023-02-06" DateLastUpdated="2023-11-11" DateCreated="2023-02-13">
        <ClinVarSubmissionID localKey="NC_000009.11:g.(104187910_104188836)_(104193180_104197990)del|MedGen:C0016751" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003800654" DateUpdated="2023-11-11" DateCreated="2023-02-13" Type="SCV" Version="2" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-01-06">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">20848650</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22494545</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">3430936</ID>
          </Citation>
          <Comment>Variant summary: The variant identified by MLPA or other technology involves the deletion of exons 2-6 in the ALDOB gene, where exon 2 contains the initiator codon. A presumed nomenclature of c.(-11+1_-10-1)_(624+1_625-1)del has been designated for the purposes of this classification. Since this deletion includes the initiation codon, it is expected to result in an absent or shortened protein product, a known mechanism of disease. A deletion that includes exons 2-6 of the ALDOB gene (Size: 6,448 bp, Position: 9:104188774-104195222) was found at a frequency of 9.2e-05 (i.e. 2 alleles) in 21694 control chromosomes (gnomAD structural variants dataset). Deletion of exons 2-6 has been reported in the literature in multiple homozygous and compound heterozygous individuals affected with Hereditary Fructose Intolerance (e.g. Esposito_2010, Wang_2012, Ferri_2012). These data indicate that the variant is very likely to be associated with disease. One clinical diagnostic laboratory has submitted clinical-significance assessments for this variant to ClinVar after 2014 and classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ALDOB" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000009.11:g.(104187910_104188836)_(104193180_104197990)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0016751" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12766635</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7081273" TraitType="Disease" MappingType="XRef" MappingValue="C0016751" MappingRef="MedGen">
        <MedGen CUI="C0016751" Name="Hereditary fructosuria" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

